TipRanks
Advertisement

USFE - ETF AI Analysis

Compare

Top Page

USFE

First Eagle US Equity ETF (USFE)

Rating:70Outperform
Price Target:
USFE, the First Eagle US Equity ETF, has a solid overall rating driven largely by strong, well-positioned holdings like Alphabet (GOOG), Oneok (OKE), and Newmont (NEM), which combine robust financial performance with attractive growth or income potential. The fund also includes more mixed names such as Philip Morris (PM), where high leverage and a bearish technical outlook temper its positives, and some holdings with valuation concerns, which slightly weigh on the rating. A key risk factor is the ETF’s reliance on a relatively small group of large positions, meaning issues at a few major holdings could have an outsized impact on the fund.
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains so far this year and over the past few months, showing positive momentum.
Balanced Sector Mix
Holdings are spread across health care, technology, financials, energy, and other sectors, which helps reduce the impact of weakness in any single industry.
Several Strong Top Holdings
Key positions like Oneok, Bank of New York Mellon, Newmont Mining, and Elevance Health have shown strong year-to-date performance, supporting the fund’s overall results.
Negative Factors
High U.S. Concentration
The fund is heavily invested in U.S. companies with very little exposure outside the U.S., which limits geographic diversification.
Mixed Performance Among Top Holdings
Several large positions such as Becton Dickinson, Meta Platforms, Salesforce, Workday, and HCA Healthcare have shown weak year-to-date performance, which can drag on returns if the trend continues.
Moderate Expense Ratio
The fund’s expense ratio is not especially low, meaning investors pay a noticeable ongoing fee compared with some cheaper ETFs.

USFE vs. SPDR S&P 500 ETF (SPY)

USFE Summary

First Eagle US Equity ETF (USFE) is an actively managed fund that invests in a wide mix of U.S. companies of all sizes, with a focus on stocks the managers believe are trading for less than they’re really worth. It doesn’t track a set index, but instead follows a value-focused approach across many sectors, holding well-known names like Alphabet (Google) and Meta Platforms (Facebook). Someone might invest in USFE for broad U.S. stock market exposure with a value tilt and diversification across industries. A key risk is that its stock prices can rise and fall with the overall market and its value style can lag growth stocks for long periods.
How much will it cost me?This ETF has an expense ratio of 0.45%, which means you’ll pay about $4.50 per year for every $1,000 you invest. That’s higher than the cost of many index (passively managed) ETFs, mainly because this fund is actively managed, with managers researching and selecting individual stocks.
What would affect this ETF?USFE could benefit if the U.S. economy stays resilient, as its broad mix of sectors and value focus may help it find solid companies that are temporarily out of favor, especially in areas like health care, communication services, and technology where leaders such as Alphabet and Meta could gain from ongoing digital and medical trends. On the other hand, rising interest rates, tighter regulations on big tech or financial firms, or a downturn that hits value stocks or U.S. markets in general could weigh on the fund’s performance despite its diversification.

USFE Top 10 Holdings

USFE’s story is driven by a mix of sturdy value names and a few tech high‑flyers that have hit some turbulence. Energy player Oneok and gold miner Newmont are rising, giving the fund a solid lift from the commodity side, while Bank of New York Mellon adds steady strength from financials. On the flip side, big tech holdings like Alphabet and Workday have seen more mixed, recently lagging action, and Salesforce’s sharp run‑up looks a bit stretched. With all major positions in U.S. companies and no single sector dominating, the fund leans diversified but with a clear value‑tilted backbone.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Oneok5.01%$149.04K$60.91B32.26%
82
Outperform
Becton Dickinson4.60%$137.08K$48.44B-4.81%
67
Neutral
Alphabet Class C4.23%$125.88K$4.12T38.97%
82
Outperform
Meta Platforms4.05%$120.50K$1.65T-14.24%
76
Outperform
Elevance Health3.69%$109.97K$90.81B34.31%
76
Outperform
Bank of New York Mellon3.69%$109.75K$110.37B52.76%
75
Outperform
Salesforce3.27%$97.44K$203.87B2.04%
80
Outperform
Newmont Mining3.22%$95.87K$133.62B60.01%
81
Outperform
HCA Healthcare3.11%$92.67K$92.43B5.38%
70
Neutral
Philip Morris2.96%$88.05K$297.79B15.02%
61
Neutral

USFE Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
36.36
Positive
100DMA
35.42
Positive
200DMA
Market Momentum
MACD
0.32
Positive
RSI
56.57
Neutral
STOCH
19.44
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For USFE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 37.70, equal to the 50-day MA of 36.36, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.32 indicates Positive momentum. The RSI at 56.57 is Neutral, neither overbought nor oversold. The STOCH value of 19.44 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for USFE.

USFE Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$3.00M0.45%
70
Outperform
$98.45M0.89%
71
Outperform
$91.86M0.30%
67
Neutral
$75.15M0.75%
69
Neutral
$45.22M0.45%
70
Outperform
$45.02M0.87%
59
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
USFE
First Eagle US Equity ETF
37.66
2.64
7.54%
BAMD
Brookstone Dividend Stock ETF
VUSV
Vanguard Wellington U.S. Value Active ETF
SASS
M.D. Sass Concentrated Value ETF
GVLE
Goldman Sachs Value Opportunities ETF
CVAR
Cultivar ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement